Home / Import refusals / AEK-9181116-4/30001/1

AEK-9181116-4/30001/1

AstraZeneca Pharmaceuticals LP — FEI 2518137

Recent inspections

  • 1247294 (NAI Fri Oct 04 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1219696 (NAI Wed Sep 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 930780 (NAI Fri Jun 19 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 895234 (NAI Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 873394 (NAI Mon Apr 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Compliance actions

Other import refusals

  • 799-1544392-9/10001/1 (Tue Feb 24 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-9333932-1/20001/1 (Thu Jan 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • AEK-7869884-0/10001/1 (Fri Dec 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • NUV-3852229-1/120002/1 (Tue Nov 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)
  • 799-6004838-8/21/1 (Mon Mar 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) — Drugs and Biologics)

Refusal Details

Date
January 21, 2026
Country
United States
Product Category
Drugs and Biologics
Product Code
61PDA70 DAPAGLIFLOZIN (ANTI-DIABETIC)
Charges
75